Collection of referred small molecules with carefully collected activity data
2 320 compounds
To address continuously growing interested to Drug Repurposing we designed and carefully collected a Bioactive Reference Collection of over 2 300 compounds with extensive target classes’ coverage and the broadest possible therapeutic areas applications – from CNS agents and anti-infectives to anticancer drugs and steroids.
Represented collection of carefully selected compounds includes 1 040 FDA approved drugs, as well as “tool compounds” with validated biological activity, active metabolites/prodrugs, and drug candidates that are currently undergoing clinical trials.
Ready-to-use, fully referred, alternative for compound screening.
Any compound from BRC collection can be ordered individually as focused sets: target-based or by therapeutic area.
Proven and reliable
- Stringent quality control using most advanced methods.
- Synthetic chemistry capacity with professionals in organic chemistry experienced in diverse synthetic methods and techniques.
- Drugs synthesis and their functional modifications for target identification and other purposes.
Distribution of compounds by therapeutic area
Related products & services
Target identification toolbox
Additionally we provide broad functionalization of Drugs and relative actives with covalent warheads, biotin or/and dye-linking, PED-derivatization and other modifications. Versatile chemistry and the largest stock of valuable reagents enables Enamine to produce new functionalization of well-known drugs.
We combined most diverse approaches and possible structural modifications to achieve most complete representation of our Target identification tools.